Knights of Columbus Asset Advisors LLC

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1688666 NEW HAVEN, CT

Position in MDGL

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$1,940,503

-$215,319 QoQ

Shares Held

3,707

+0.1% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Knights of Columbus Asset Advisors LLC holds $22,508,527 across 17 Biotechnology names. MDGL ranks #3 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	19,677	$3,325,806
2	MIRM	Mirum Pharmaceuticals, Inc.	23,824	$2,200,861
3	MDGL	Madrigal Pharmaceuticals, Inc. This page	3,707	$1,940,503
4	CGON	CG Oncology, Inc.	23,200	$1,570,176
5	COGT	Cogent Biosciences, Inc.	39,039	$1,502,611
6	RYTM	Rhythm Pharmaceuticals, Inc.	15,589	$1,355,775
7	KYMR	Kymera Therapeutics, Inc.	15,872	$1,321,978
8	IDYA	IDEAYA Biosciences, Inc.	39,530	$1,317,139

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,940,503	3,707	+0.1%	Shares	Sole	2026-05-11
2025-12-31	$2,155,822	3,702	-3.8%	Shares	Sole	2026-02-09
2025-09-30	$1,764,923	3,848	-16.4%	Shares	Sole	2025-11-03
2025-06-30	$1,393,051	4,603	+19.0%	Shares	Sole	2025-07-22
2025-03-31	$1,280,866	3,867	-17.6%	Shares	Sole	2025-05-07
2024-12-31	$1,448,736	4,695	+82.0%	Shares	Sole	2025-02-11
2024-09-30	$547,315	2,579	-50.8%	Shares	Sole	2024-11-12
2024-06-30	$1,469,719	5,246	+1.6%	Shares	Sole	2024-07-30
2024-03-31	$1,378,727	5,163	-40.6%	Shares	Sole	2024-05-10
2023-12-31	$2,011,849	8,695	+101.8%	Shares	Sole	2024-01-31
2023-09-30	$629,286	4,309	+1.7%	Shares	Sole	2023-11-01
2023-06-30	$978,285	4,235	+630.2%	Shares	Sole	2023-08-01
2023-03-31	$140,510	580	—	Shares	Sole	2023-05-01
No filing history on record for this holder in this stock.